Who is sponsoring NCT06000332?

NCT06000332 is sponsored by Inogen Inc..

What drugs are being tested in NCT06000332?

Interventions in NCT06000332: InogenOne Rove 6 Portable Oxygen Concentrator.

What condition does NCT06000332 study?

NCT06000332 studies Nocturnal Hypoxemia.

Is NCT06000332 still recruiting?

NCT06000332 is currently completed. Last updated 5 January 2024.

Last reviewed 2024-01-05 · How we verify

NCT06000332

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of POC Pulse-dose Demand Oxygen Delivery for Nocturnal Hypoxemia

Completed NA Last updated 5 January 2024

What this trial tests

NA trial testing InogenOne Rove 6 Portable Oxygen Concentrator in Nocturnal Hypoxemia in 20 participants. Completed in 21 December 2023.

Timeline

17 October 2023

Primary endpoint
21 December 2023

21 December 2023

Quick facts

Lead sponsor	Inogen Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	17 October 2023
Primary completion	21 December 2023
Estimated completion	21 December 2023
Sites	1 location across United States

Drugs / interventions tested

InogenOne Rove 6 Portable Oxygen Concentrator

Conditions studied

Nocturnal Hypoxemia — all drugs for Nocturnal Hypoxemia →

Sponsor

Inogen Inc. — full company profile →

Who can join

Adults 40 to 80, any sex, with Nocturnal Hypoxemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to describe the effect of the Inogen Rove 6 Portable Oxygen Concentrator on peripheral oxygen saturation in adults receiving supplemental oxygen at night and examine whether the device can adequately maintain oxygen saturation during sleep.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Inogen Inc. trials

Trials by the same sponsor.

NCT06555484 — Acute Effects of Supplemental Oxygen on Memory Testing in Healthy Adult Volunteers · NA · completed
NCT05719363 — Portable Oxygen Concentrator in Non-hospitalized Patients With Chronic Heart Failure · NA · completed
NCT05212831 — Portable Oxygen Concentrator (POC) Versus Standard of Care in Long-COVID: Randomized Crossover Exploratory Pilot Study. · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06000332 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Inogen Inc.
Last refreshed: 5 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06000332.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing